BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antitubercular activity evaluation of novel unsymmetrical cyclohexane-1,2-diamine derivatives. 2012

Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Department of Chemistry, University of Delhi, Delhi, India.

A library of unsymmetrical cyclohexane-1,2-diamine derivatives were synthesized and evaluated for their activity against Mycobacterium tuberculosis H37Rv in vitro. Out of the 46 compounds synthesized, eight compounds (11h, 13a, 13e, 13f, 14a, 14c, 14d, and 15d) were found to be active at or below 6.25 µM concentration, with negligible toxicity to human red blood cells at a concentration much higher than the MIC(99) . Compound 13a was the best active compound showing inhibition at 3.125-6.25 µM, and was found to be non-hemolytic up to 500 µg/mL concentration.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D003510 Cyclohexanes Six-carbon alicyclic hydrocarbons.
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D018675 Toxicity Tests An array of tests used to determine the toxicity of a substance to living systems. These include tests on clinical drugs, foods, and environmental pollutants. Tests, Toxicity,Test, Toxicity,Toxicity Test

Related Publications

Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Synthesis, antimicrobial activity and structure-activity relationship study of N,N-dibenzyl-cyclohexane-1,2-diamine derivatives.
February 2011, European journal of medicinal chemistry,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
October 2020, Bioorganic & medicinal chemistry letters,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Synthesis and antitubercular activity of novel amino acid derivatives.
February 2012, Chemical biology & drug design,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
June 2007, Natural product research,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.
September 2017, Molecules (Basel, Switzerland),
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
June 2014, European journal of medicinal chemistry,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Chemoenzymatic preparation of optically active trans-cyclohexane-1,2-diamine derivatives: an efficient synthesis of the analgesic U-(-)-50,488.
November 2004, Chemistry (Weinheim an der Bergstrasse, Germany),
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
November 2011, Bioorganic & medicinal chemistry letters,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Synthesis and cytotoxic activity of dextran carrying cis-dichloro(cyclohexane-trans-l-1,2-diamine)platinum(II) complex.
January 1996, Journal of biomaterials science. Polymer edition,
Beena, and Seema Joshi, and Nitin Kumar, and Saqib Kidwai, and Ramandeep Singh, and Diwan S Rawat
Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
March 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!